Highlights on HIV Prevention and Antiretroviral Therapy from the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 and Expectations from CROI 2026

Creative Commons License

İnan A., Sayın-Kutlu S., SÖNMEZER M. Ç., Gökengin D.

Infectious Diseases and Clinical Microbiology, vol.8, no.1, pp.14-25, 2026 (ESCI, Scopus, TRDizin) identifier

  • Publication Type: Article / Review
  • Volume: 8 Issue: 1
  • Publication Date: 2026
  • Doi Number: 10.36519/idcm.2026.999
  • Journal Name: Infectious Diseases and Clinical Microbiology
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.14-25
  • Keywords: antiretroviral therapy, CROI, HIV prevention, long-acting antiretrovirals
  • Hacettepe University Affiliated: Yes

Abstract

The Conference on Retroviruses and Opportunistic Infections (CROI) was held from March 9 to 12, 2025, in San Francisco, California, United States (US). The rapidly evolving field of HIV infection was reflected in data presented from cutting-edge scientific research at the conference. This review highlights data presented on two prominent topics during the meeting: HIV prevention and antiretroviral therapy (ART), with the aim of summarizing new data for the reader. The review also outlines the authors’ expectations for CROI 2026, which will be held from February 22 to 25, 2026, in Denver, Colorado, US.